Search

everythinglearnresearchcommunity

for

Search:↓

A low-glycemic diet improved hormone levels and well-being in overweight women with high androgen levels.

A woman with acromegaly experienced severe hair loss from a drug called Lanreotide Autogel, which improved after stopping the treatment.

The contraceptive reduced hair growth and altered hormone levels in hirsute women.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

Diagnosing Polycystic Ovary Syndrome is hard due to varying symptoms, no set criteria, and the need for better tests and education.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

A woman developed Cushing syndrome and adrenal insufficiency from using fluticasone and ritonavir together.

A Chinese family had a child with a specific gene mutation causing vitamin D-resistant rickets, but the child improved with calcium and low-dose calcitriol.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

The document concludes that more research is needed to fully understand the causes of PCOS.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

Higher SHBG levels are linked to less severe hair loss in women, but vitamin D levels don't seem to affect hair loss.

Hair loss in women aged 20-30 is often linked to deficiencies in Vitamin D, zinc, ferritin, and haemoglobin, as well as low SHBG levels in those with irregular periods.

Nafarelin may effectively treat excessive hair growth in women by reducing certain hormone levels.

A subtle androgen receptor abnormality can allow normal male development and sometimes fertility despite partial androgen resistance.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

Women with acromegaly often have irregular periods due to hormone imbalances and growth hormone effects.

Recombinant gonadotropins improve future fertility in CHH patients.

Melatonin may inhibit melanoma growth and has potential as a cancer therapy aid, but its effects on human skin pigmentation need more research.

Many women with polycystic ovarian disease show symptoms like excessive hair growth, acne, hair loss, and have high levels of certain hormones.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.